Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 18 de 18
Filter
1.
Aliment Pharmacol Ther ; 38(8): 946-54, 2013 Oct.
Article in English | MEDLINE | ID: mdl-23981105

ABSTRACT

BACKGROUND: The proportion (and even the reality) of peptic ulcer disease (PUD) not related to H. pylori or NSAID/aspirin is debated. AIM: To analyse the current epidemiological and clinical characteristics of peptic ulcer disease in French general hospitals. METHODS: Prospective multicentre study of patients with peptic ulcer disease in 32 French general hospitals over 1 year. H. pylori status was assessed by histology, and/or serology and/or C13-urea breath test. NSAID/aspirin intake (obtained by direct interview) and data about concomitant diseases were collected on the day of endoscopy. RESULTS: Nine hundred and thirty-three patients were selected during the year 2009. After exclusion of 118 patients with only erosive duodenitis, 24 with major missing data, 13 with other causes of ulcer and 65 negative for H. pylori by only one test, 713 patients were classified into four groups: 285 (40.0%) had only H. pylori infection; 133 (18.7%) only gastrotoxic drugs; 141 (19.8%) had both and 154 (21.6%) neither H. pylori infection nor gastrotoxic drug intake ('idiopathic ulcers'). Patients with idiopathic ulcers differed in many ways both from H. pylori and NSAID/aspirin groups. However, multivariate analysis identified only three independent predictors: age, French metropolitan origin and the presence of comorbidities. CONCLUSION: In a general hospital-based population in France, peptic ulcer disease appears idiopathic in a fifth of cases.


Subject(s)
Peptic Ulcer/etiology , Adolescent , Adult , Aged , Aged, 80 and over , Anti-Inflammatory Agents, Non-Steroidal/adverse effects , Aspirin/adverse effects , Breath Tests , Female , France/epidemiology , Helicobacter Infections/complications , Helicobacter Infections/diagnosis , Helicobacter Infections/epidemiology , Helicobacter Infections/microbiology , Helicobacter pylori/isolation & purification , Hospitalization/statistics & numerical data , Hospitals, General/statistics & numerical data , Humans , Male , Middle Aged , Peptic Ulcer/diagnosis , Peptic Ulcer/epidemiology , Prospective Studies , Risk Factors , Young Adult
4.
Aliment Pharmacol Ther ; 26(4): 565-76, 2007 Aug 15.
Article in English | MEDLINE | ID: mdl-17661760

ABSTRACT

BACKGROUND: Epidemiological data concerning hepatitis B are scarce in France. AIM: To describe epidemiological, clinical, virological and histological features of HBsAg-positive patients followed at non-academic hospitals in France. METHODS: Clinical, biological, virological and histological data of all HBsAg-positive consecutive patients observed from April 1, 2001 to May 31, 2002 in participating centres were recorded prospectively. Multivariate analyses of factors associated with significant fibrosis and cirrhosis were performed. RESULTS: Nearly 1166 HBsAg-positive patients were seen in the 58 centres: 671 males and 495 females from metropolitan France (32%) and from outside metropolitan France (68%); mean age 41 +/- 15 years. Twenty-nine percent of patients were probable HBsAg inactive carriers, while 50% had chronic hepatitis; 43% of these were HBeAg-positive and 57% HBeAg-negative. Liver biopsy had been performed in 558 (51%) patients; 205 (17.6%) patients had cirrhosis. By multivariate analysis, factors associated with significant fibrosis were: age >40 years (P < 0.05), HBeAg-negative status (P < 0.02) and histological activity (P < 0.0001). Factors associated with cirrhosis: age (P < 0.0001), platelet count <150 000/mm(3) (P < 0.0001) and viral co-infection (P < 0.03). CONCLUSION: HBV infection represents a significant workload for hepatogastroenterologists at non-academic hospitals in France.


Subject(s)
Hepatitis B, Chronic/epidemiology , Adult , Female , France/epidemiology , Hepatitis B e Antigens/blood , Hepatitis B virus/isolation & purification , Hepatitis B, Chronic/blood , Humans , Liver Cirrhosis/epidemiology , Male , Prevalence , Risk Factors , Sex Factors
5.
Histopathology ; 48(4): 417-23, 2006 Mar.
Article in English | MEDLINE | ID: mdl-16487363

ABSTRACT

AIM: To evaluate clinical, biological and immunological features of patients with increased duodenal intraepithelial lymphocytes (IELs), and its relation to Helicobacter pylori (HP) and coeliac disease (CD). METHODS: We have studied all patients accrued over a 4-year period with increased duodenal IELs. Those patients were recalled for biological and immunological evaluation and a second endoscopy. RESULTS: Twenty-three from a total of 639 patients were identified and 17 of them were included in the study. The median duodenal IEL count was 59 per 100 epithelial cells. Twelve (71%) patients were HP+; eight of them received HP eradication. At the second endoscopy the duodenal IEL count was significantly lower 2 months after HP eradication (73 versus 28), while the IEL count was unchanged in those patients seronegative for HP (n = 5) or those in whom it was not eradicated (n = 4) (55 versus 55). No patient had coeliac antibodies, four expressed HLA-DQ2, lower than in the general population, and the prevalence of CD was 2% (12/639 patients). CONCLUSION: In some cases an increased duodenal IEL count may be due to an inappropriate host response to HP. HP screening and eradication should be considered before recommending a gluten-free diet.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Duodenum/drug effects , Helicobacter Infections/drug therapy , Helicobacter pylori/drug effects , Lymphocytosis/prevention & control , Biopsy , Celiac Disease/complications , Celiac Disease/immunology , Cell Count , Duodenum/microbiology , Duodenum/pathology , Endoscopy, Gastrointestinal , Epithelium/drug effects , Epithelium/microbiology , Epithelium/pathology , Female , HLA-DQ Antigens/immunology , HLA-DQ beta-Chains , HLA-DR4 Antigen/immunology , Helicobacter Infections/complications , Helicobacter Infections/microbiology , Humans , Lymphocytes/pathology , Lymphocytosis/etiology , Lymphocytosis/pathology , Male , Stomach/drug effects , Stomach/microbiology , Stomach/pathology
6.
Ann Med Interne (Paris) ; 151(5): 417-20, 2000 Sep.
Article in French | MEDLINE | ID: mdl-11033479

ABSTRACT

Cholesterol crystal embolization is a well-known disorder resulting from release of cholesterol crystals from ulcerous atherosclerotic plaques. Gastrointestinal involvement occurs in about a third of cases, but it is usually asymptomatic. We report a case of an old woman with small bowel obstruction secondary to atheromatous embolism. She was treated by acenocoumarol for atrial fibrillation and pulmonary embolism. Two weeks before admission for small bowel obstruction, she had a watery diarrhea. After 3 weeks of parenteral nutrition, she underwent resection of the involved ileum. Pathological examination showed a small bowel stricture secondary to atheromatous embolism. Cholesterol emboli should be considered as a potential cause of small bowel obstruction in old patient who has taken anticoagulant therapy or after vascular invasive procedure.


Subject(s)
Arteriosclerosis/complications , Embolism, Cholesterol/complications , Intestinal Obstruction/etiology , Intestine, Small/blood supply , Ischemia/etiology , Acenocoumarol/adverse effects , Aged , Aged, 80 and over , Anticoagulants/adverse effects , Arteriosclerosis/pathology , Arteriosclerosis/surgery , Atrial Fibrillation/complications , Atrial Fibrillation/drug therapy , Embolism, Cholesterol/pathology , Embolism, Cholesterol/surgery , Female , Humans , Pulmonary Embolism/complications , Pulmonary Embolism/drug therapy
7.
Gastroenterol Clin Biol ; 24(6-7): 671-4, 2000.
Article in French | MEDLINE | ID: mdl-10962392

ABSTRACT

Reactivation of chronic infection is a serious complication during and especially after the withdrawal of cancer chemotherapy in hepatitis B virus carriers. Mortality is high, ranging from 4 to 20%. We report two cases of severe reactivation, after withdrawal of chemotherapy for chronic lymphocytic leukemia in one case and for a bladder tumor in the other. Recovery occurred with lamivudine therapy. Morbidity and mortality are common in these cases, especially when intensive chemotherapy and/or chronic hepatitis and/or precore mutants viruses are involved. Although lamivudine seems to be effective in these cases, prophylactic use has not been clearly defined and must be evaluated.


Subject(s)
Antineoplastic Agents/administration & dosage , Antiviral Agents/therapeutic use , Hepatitis B/drug therapy , Lamivudine/therapeutic use , Aged , Female , Hepatitis B/complications , Humans , Leukemia, Lymphocytic, Chronic, B-Cell/complications , Leukemia, Lymphocytic, Chronic, B-Cell/drug therapy , Male , Recurrence , Urinary Bladder Neoplasms/complications , Urinary Bladder Neoplasms/drug therapy
14.
Hepatology ; 4(5): 893-6, 1984.
Article in English | MEDLINE | ID: mdl-6148299

ABSTRACT

Serum activity of the mitochondrial isoenzyme of aspartate aminotransferase (mAST) was measured with an immunological method in 74 subjects. Fourty-six were chronic alcoholics with (30) or without (16) obvious alcoholic liver disease; 28 were nonalcoholic controls among whom 14 had acute or chronic viral hepatitis, the remaining 14 being healthy individuals. Mean mAST activity was much higher in all the alcoholic subjects, with or without liver disease, 10.4 and 1.95 units per liter, respectively, than in the healthy controls (0.43, p less than 0.001). The mean mAST to total AST ratio was similar in the healthy controls and in the patients with viral hepatitis (2.98 and 3.19%, NS), whereas it was about 4 times higher in the alcoholics with a sensitivity which reached 93% in the patients with alcoholic liver disease and 100% in those without. Both gamma-glutamyl transpeptidase and glutamate dehydrogenase serum activities were far less sensitive and specific. As almost all chronic alcoholics had similar abnormal values of mAST/total AST ratio, this leads to question whether "normal" liver may really exist in any of such subjects.


Subject(s)
Alcoholism/diagnosis , Aspartate Aminotransferases/blood , Hepatitis, Alcoholic/diagnosis , Isoenzymes/blood , Adult , Aged , Alcoholism/enzymology , Female , Glutamate Dehydrogenase/blood , Hepatitis, Alcoholic/enzymology , Hepatitis, Viral, Human/diagnosis , Humans , Male , Middle Aged , Mitochondria, Liver/enzymology , gamma-Glutamyltransferase/blood
18.
Anesth Analg (Paris) ; 38(9-10): 533-6, 1981.
Article in French | MEDLINE | ID: mdl-7036794

ABSTRACT

To determine the indications of body position, continuous positive airway pressure and independent lung ventilation in unilateral lung disease, we turned 10 patients with overwhelming unilateral lung disease from supine to lateral position. All patients were breathing spontaneously with a mask, then associated with continuous airway pressure (10 cm H2O PEEP) in five cases. During these spontaneous ventilation methods, hemodynamic parameters did not change, but arterial blood oxygen tension increased and intra-pulmonary shunting decreased significantly. Final recovery was obtained in 7 cases. In the 3 others, mechanical ventilation was needed because spontaneous breathing methods were ineffective in improving blood gases. Lateral position and conventional ventilation with positive airway pressure were also ineffective. Only independent ventilation enhanced arterial blood oxygen tension. But only one patient survived. We conclude that spontaneous breathing methods are able to provide successful treatment in most of patients with unilateral lung disease. In other patients, only independent lung ventilation is effective.


Subject(s)
Positive-Pressure Respiration/methods , Posture , Respiration , Respiratory Insufficiency/therapy , Adult , Blood Gas Analysis , Hemodynamics , Humans , Male , Middle Aged , Respiratory Insufficiency/physiopathology
SELECTION OF CITATIONS
SEARCH DETAIL
...